SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Bretschneider JH. Myocardial protection. Thorac Cardiovasc Surg 1980; 1980: 285.
  • 2
    Gubernatis G, Pichlmayr R, Lamesch P, Grosse H, Bornscheuer A, Meyer H, et al. HTK-solution (Bretschneider) for human liver transplantation: first clinical experiences. Langenbecks Arch Chir 1990; 375: 6670.
  • 3
    Hatano E, Kiuchi T, Tanaka A, Shinohara H, Kitai T, Satoh S, et al. Hepatic preservation with histidine-tryptophan-ketoglutarate solution in living-related and cadaveric liver transplantation. Clin Sci (Lond) 1997; 93: 81.
  • 4
    Erhard J, Lange R, Scherer R, Kox WJ, Bretshneider HJ, Gebhard MM, Eigler FW. Comparison of histidine-tryptophan-ketoglutarate (HTK) solution versus University of Wisconsin (UW) solution for organ preservation in human liver transplantation: a prospective, randomized study. Transpl Int 1994; 7: 177181.
  • 5
    Fridell JA, Agarwal A, Milgrom ML, Goggins WC, Murdock P, Pescovitz MD. Comparison of histidine-tryptophan-ketoglutarate solution and university of Wisconsin solution for organ preservation in clinical pancreas transplantation. Transplantation 2004; 77: 13041306.
  • 6
    Agarwal A, Goggins WC, Pescovitz MD, Milgrom ML, Murdock P, Fridell JA. Comparison of histidine-tryptophan ketoglutarate (HTK) solution and University of Wisconsin (UW) solution with pulsatile perfusion in clinical kidney transplantation. Transpl Proc 2005; 37(5): 20162019.
  • 7
    de Boer J, De Meester J, Smits JM, Groenewoud AF, Bok A, van der Velde O, et al. Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins. Transpl Int 1999; 12: 447.
  • 8
    Potdar S, Malek S, Eghtesad B, Shapiro R, Basu A, Patel K, et al. Initial experience using histidine-tryptophan-ketoglutarate solution in clinical pancreas transplantation. Clin Transplant 2004; 18: 661665.
  • 9
    Isemer FE, Ludwig A, Schunck O, Bretschneider JH, Peiper HJ. Kidney procurement with the HTK solution of Bretschneider. Transplant Proc 1988; 20: 885886.
  • 10
    Lange R, Erhard J, Rauen U, de Groot H, Eigler FW. Hepatocellular injury during preservation of human livers with UW and HTK solution. Transplant Proc 1997; 29: 400402.
  • 11
    Canelo R, Hakim NS, Ringe B. Experience with hystidine tryptophan ketoglutarate versus University of Wisconsin preservation solutions in transplantation. Int Surg 2003; 88: 145151.
  • 12
    Pokorny H, Rasoul-Rockenschaub S, Langer F, Windhager F, Rosensting A, Lange R. Histidine-tryptophan-ketoglutarate solution for organ preservation in human liver transplantation: a prospective multi-centre observation study. Transplant Int 2004; 17: 256.
  • 13
    Chan SC, Liu CL, Lo CM, Fan ST. Applicability of histidine-tryptophan-ketoglutarate solution in right lobe adult-to-adult live donor liver transplantation. Liver Transpl 2004; 10: 14151421.
  • 14
    Testa G, Malago M, Nadalin S, Treptow B, Paul A, Frilling A, Broelsch CE. Histidine-tryptophan-ketoglutarate versus University of Wisconsin solution in living donor liver transplantation: results of a prospective study. Liver Transpl 2003; 9: 82228226.